Table 4 Survival outcomes for all patients with dedifferentiated CS of the pelvis treated with either palliative or curative intent from available literature over the last 30 years
From: Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment
Study | Number of patients | Mortality rate | Time to disease recurrence, months | Notes |
|---|---|---|---|---|
Frassica et al. [5] | 23 | 19–21 (82.6%–91.3%) | N/A | Calculated from available data (pelvic data not explicitly reported) |
Liu et al. [9] | 13 | 12 (92.3%) | 10.6 | |
Grimer et al. [10] | 95 | N/A | N/A | No pelvis survival outcomes reported |
Mavrogenis et al. [12] | 32 | 22 (68.8%) | 13 | Calculated from available data on Kaplan–Meier curves |
Weber et al. [19] | 1 | 1 (100%) | 8 | |
Sheth et al. [20] | 13 | 10 (76.9%) | 4.5 | |
Current study | 31 | 25 (80.6%) | 6.2 |